← Open Payments lookup

CLARENCE VASTINE: Open Payments

NPI 1902121379 · GOODYEAR, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,275 in 70 payments from 17 companies in 2025. Trend: 2023 $1,162 · 2024 $1,156 · 2025 $1,275

Food & beverage: $1,275
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$221
GlaxoSmithKline, LLC.11$173
Novo Nordisk Inc14$162
ABBVIE INC.10$152
Lilly USA, LLC10$136
Corcept Therapeutics3$75
Bayer Healthcare Pharmaceuticals Inc.4$66
Astellas Pharma US Inc2$63
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$60
Boehringer Ingelheim Pharmaceuticals, Inc.2$29

Products named: AIRSUPRA, TRELEGY ELLIPTA, UBRELVY, MOUNJARO, Ozempic, Korlym, Kerendia, Veozah.

Industry payments across AZ — which companies pay providers there.